BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 30867554)

  • 21. Vaccinations with recombinant variants of Aspergillus fumigatus allergen Asp f 3 protect mice against invasive aspergillosis.
    Ito JI; Lyons JM; Hong TB; Tamae D; Liu YK; Wilczynski SP; Kalkum M
    Infect Immun; 2006 Sep; 74(9):5075-84. PubMed ID: 16926399
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of invasive aspergillosis risk of immunocompromised patients alternatively hospitalized in hematology intensive care unit and at home.
    Rocchi S; Reboux G; Larosa F; Scherer E; Daguindeau E; Berceanu A; Deconinck E; Millon L; Bellanger AP
    Indoor Air; 2014 Dec; 24(6):652-61. PubMed ID: 24621176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of T-cell responses to Aspergillus fumigatus antigens in healthy individuals and patients with hematologic malignancies.
    Hebart H; Bollinger C; Fisch P; Sarfati J; Meisner C; Baur M; Loeffler J; Monod M; Latgé JP; Einsele H
    Blood; 2002 Dec; 100(13):4521-8. PubMed ID: 12393638
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel preventative strategies against invasive aspergillosis.
    Mantadakis E; Samonis G
    Med Mycol; 2006 Sep; 44(Supplement_1):S327-S332. PubMed ID: 30408925
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Novel Strategy to Identify Haematology Patients at High Risk of Developing Aspergillosis.
    Griffiths JS; White PL; Thompson A; da Fonseca DM; Pickering RJ; Ingram W; Wilson K; Barnes R; Taylor PR; Orr SJ
    Front Immunol; 2021; 12():780160. PubMed ID: 34975870
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Peroxiredoxin Asp f3 Acts as Redox Sensor in
    Boysen JM; Saeed N; Wolf T; Panagiotou G; Hillmann F
    Genes (Basel); 2021 Apr; 12(5):. PubMed ID: 33946853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generation of Aspergillus-specific T lymphocytes with cytotoxic activity.
    Ramadan G
    Egypt J Immunol; 2004; 11(2):59-70. PubMed ID: 16734118
    [TBL] [Abstract][Full Text] [Related]  

  • 28. What makes Aspergillus fumigatus a successful pathogen? Genes and molecules involved in invasive aspergillosis.
    Abad A; Fernández-Molina JV; Bikandi J; Ramírez A; Margareto J; Sendino J; Hernando FL; Pontón J; Garaizar J; Rementeria A
    Rev Iberoam Micol; 2010; 27(4):155-82. PubMed ID: 20974273
    [TBL] [Abstract][Full Text] [Related]  

  • 29. "Cerberus" T Cells: A Glucocorticoid-Resistant, Multi-Pathogen Specific T Cell Product to Fight Infections in Severely Immunocompromised Patients.
    Koukoulias K; Papayanni PG; Georgakopoulou A; Alvanou M; Laidou S; Kouimtzidis A; Pantazi C; Gkoliou G; Vyzantiadis TA; Spyridonidis A; Makris A; Chatzidimitriou A; Psatha N; Anagnostopoulos A; Yannaki E; Papadopoulou A
    Front Immunol; 2020; 11():608701. PubMed ID: 33537032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and Microbiological Characteristics of Proven Invasive Aspergillosis Due to Rare/Cryptic Species in Allogeneic Hematopoietic Stem Cell Transplant Recipients.
    Yamamuro R; Kimura M; Asano-Mori Y; Abe M; Nakamura S; Umeyama T; Yamagoe S; Miyazaki Y; Ogura S; Sakoh T; Mitsuki T; Yamaguchi K; Yuasa M; Kaji D; Kageyama K; Nishida A; Taya Y; Ishiwata K; Takagi S; Yamamoto H; Yamamoto G; Uchida N; Wake A; Taniguchi S; Araoka H
    Antimicrob Agents Chemother; 2022 Jan; 66(1):e0163021. PubMed ID: 34780271
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stimulation by means of dendritic cells followed by Epstein-Barr virus-transformed B cells as antigen-presenting cells is more efficient than dendritic cells alone in inducing Aspergillus f16-specific cytotoxic T cell responses.
    Zhu F; Ramadan G; Davies B; Margolis DA; Keever-Taylor CA
    Clin Exp Immunol; 2008 Feb; 151(2):284-96. PubMed ID: 18005260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proteomic Profiling of Serological Responses to Aspergillus fumigatus Antigens in Patients with Invasive Aspergillosis.
    Teutschbein J; Simon S; Lother J; Springer J; Hortschansky P; Morton CO; Löffler J; Einsele H; Conneally E; Rogers TR; Guthke R; Brakhage AA; Kniemeyer O
    J Proteome Res; 2016 May; 15(5):1580-91. PubMed ID: 26974881
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adjunctive interferon-γ immunotherapy in a pediatric case of Aspergillus terreus infection.
    Assendorp EL; Gresnigt MS; Sprenkeler EGG; Meis JF; Dors N; van der Linden JWM; Henriet SSV
    Eur J Clin Microbiol Infect Dis; 2018 Oct; 37(10):1915-1922. PubMed ID: 30027379
    [TBL] [Abstract][Full Text] [Related]  

  • 34. T cell vaccination in mice with invasive pulmonary aspergillosis.
    Cenci E; Mencacci A; Bacci A; Bistoni F; Kurup VP; Romani L
    J Immunol; 2000 Jul; 165(1):381-8. PubMed ID: 10861075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A breath fungal secondary metabolite signature to diagnose invasive aspergillosis.
    Koo S; Thomas HR; Daniels SD; Lynch RC; Fortier SM; Shea MM; Rearden P; Comolli JC; Baden LR; Marty FM
    Clin Infect Dis; 2014 Dec; 59(12):1733-40. PubMed ID: 25342502
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaccine progress.
    Ito JI; Lyons JM; Diaz-Arevalo D; Hong TB; Kalkum M
    Med Mycol; 2009; 47 Suppl 1():S394-400. PubMed ID: 19247869
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular allergen sensitization of Aspergillus fumigatus between allergic bronchopulmonary aspergillosis and A fumigatus-sensitized asthma in Guangzhou, Southern China.
    Luo W; Hu H; Wu Z; Wei N; Huang H; Zheng P; Liu Y; Sun B
    J Clin Lab Anal; 2020 Oct; 34(10):e23448. PubMed ID: 32614101
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aspergillus Fumigatus antigen detection in sera from patients at risk for invasive aspergillosis.
    Chumpitazi BF; Pinel C; Lebeau B; Ambroise-Thomas P; Grillot R
    J Clin Microbiol; 2000 Jan; 38(1):438-43. PubMed ID: 10618137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum IgG responses against Aspergillus proteins before hematopoietic stem cell transplantation or chemotherapy identify patients who develop invasive aspergillosis.
    Du C; Wingard JR; Cheng S; Nguyen MH; Clancy CJ
    Biol Blood Marrow Transplant; 2012 Dec; 18(12):1927-34. PubMed ID: 22824184
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polymerase chain reaction blood tests for the diagnosis of invasive aspergillosis in immunocompromised people.
    Cruciani M; Mengoli C; Barnes R; Donnelly JP; Loeffler J; Jones BL; Klingspor L; Maertens J; Morton CO; White LP
    Cochrane Database Syst Rev; 2019 Sep; 9(9):CD009551. PubMed ID: 31478559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.